Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Hydromorphone is considered extremely addictive with high abuse potential, classified under Schedule II. Compulsive redosing is commonly reported, and the intense physical and cognitive euphoria contribute to its reinforcing properties.
Physical dependence develops with chronic use, and withdrawal symptoms may occur if the drug is suddenly stopped. Withdrawal effects include abdominal pain, anxiety, panic attacks, depression, muscle and joint pain, nausea, vomiting, sweating, and piloerection. Some users cannot tolerate the withdrawal symptoms, resulting in continued drug use.
Overdose is characterized by respiratory depression progressing to apnea, circulatory collapse, cardiac arrest, and death. Fatal overdoses are most commonly caused by respiratory depression, which is dose-related and significantly increased when combined with other CNS depressants. The risk of fatal overdose rises sharply after periods of cessation due to reduced tolerance.
| Species | Route | Value |
|---|---|---|
| mouse | IV | 104 mg/kg |
| mouse | oral | 84 mg/kg |
Heavy dosages cause respiratory depression that can progress to fatal or dangerous levels of oxygen deprivation; this effect is dose-related and represents the primary cause of opioid overdose deaths.
Prolonged use, high dosage, or kidney dysfunction may cause neuroexcitatory symptoms including tremor, myoclonus, agitation, and cognitive dysfunction; this neurotoxicity is less pronounced than with some other opioid classes such as pethidine derivatives.
Heavy chronic use often causes temporary hypogonadism or hormone imbalance, consistent with other opioids in this class.
Chronic use commonly causes constipation, with tolerance to this effect developing particularly slowly compared to other opioid effects; this is one of the few long-term complications from unadulterated hydromorphone aside from dependence.
Urinary retention is recognized as a major hazard of hydromorphone use, occurring as an acute effect during intoxication.
Hallucinations may occur as a side effect, listed among more common adverse effects particularly in ambulatory patients and those not experiencing severe pain.
Seizures are listed among serious potential side effects, though they are not commonly reported with hydromorphone alone and appear to be a relatively rare occurrence.
Hydromorphone is a semi-synthetic opioid derived from morphine through hydrogenation, producing a more potent hydrogenated ketone derivative. The compound has been available for clinical use since approximately 1920 and was patented in 1923.…
Controlled drug under the Poisons Standard. Illegal to possess without a valid prescription or license. Schedule 8 substances are those with high abuse potential requiring restricted supply.
Controlled under Schedule I of the Controlled Drugs and Substances Act. Note that Canadian schedules differ significantly from US scheduling classifications.
Classified as a Schedule II controlled substance under Russian narcotics legislation. Unauthorized possession and distribution are prohibited.
Controlled substance specifically listed under Verzeichnis A of Swiss narcotics legislation. Medicinal use is permitted with appropriate authorization.
Controlled under the Misuse of Drugs Act 1971. Class A designation carries the most severe penalties for unauthorized possession or supply. Schedule 2 permits medical prescribing under strict controls.
Legal for medical use under the Arzneimittelgesetz (AMG). Possession or sale without a valid prescription is illegal under the Suchtmittelgesetz (SMG - Narcotics Act).
Controlled substance under Anlage III of the Betäubungsmittelgesetz (Narcotics Act). Can only be prescribed using a narcotic prescription form (Betäubungsmittelrezept).
Regulated as a prescription-only medication. Available for medical use but requires valid prescription from authorized healthcare provider.
Requires a 'red prescription' (kırmızı reçete) for dispensing, indicating strict controlled substance status. Illegal to sell or possess without valid prescription.
Controlled substance under the Controlled Substances Act. Illegal to sell without a DEA license and illegal to buy or possess without a valid license or prescription. Classified as having high addiction potential but accepted medical use.
16 sources cited